» Articles » PMID: 10867641

The Mitogenic Activity of Fibroblast Growth Factor-1 Correlates with Its Internalization and Limited Proteolytic Processing

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 2000 Jun 27
PMID 10867641
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The fibroblast growth factor-1 (FGF-1) mitogenic signal transduction pathway is not well characterized, and evidence indicates that FGF-1 binding to and activation of cell-surface receptors is not solely sufficient for a full mitogenic response. Although initiation of the phosphorylation signaling cascades are likely important in FGF-1-induced mitogenic signaling, there appear to be additional signaling requirements. In this study, we demonstrate that FGF-1 internalization and subsequent processing correlates with the mitogenic potential of the growth factor on NIH 3T3 cells. Using site-directed mutants of FGF-1 and inhibitors of the endocytic and degradative pathways, we provide evidence for growth factor internalization and exposure to an acidic environment as necessary components of FGF-1-induced mitogenesis. In addition, a protease-sensitive event(s) appears critical for a complete mitogenic response to FGF-1, whereas, this protease sensitivity was not detected under the same conditions for serum-stimulated mitogenesis. Therefore, proteolytic modification of internalized FGF-1 may result in the activation of additional, intracellular signaling events.

Citing Articles

Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy.

Szlachcic A, Zakrzewska M, Lobocki M, Jakimowicz P, Otlewski J Drug Des Devel Ther. 2016; 10:2547-60.

PMID: 27563235 PMC: 4984993. DOI: 10.2147/DDDT.S105896.


Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.

Heger M, van Golen R, Broekgaarden M, van den Bos R, Neumann H, van Gulik T Lasers Med Sci. 2013; 29(2):405-22.

PMID: 24232911 DOI: 10.1007/s10103-013-1490-3.


The FGF-2-derived peptide FREG inhibits melanoma growth in vitro and in vivo.

Aguzzi M, Faraone D, DArcangelo D, De Marchis F, Toietta G, Ribatti D Mol Ther. 2010; 19(2):266-73.

PMID: 20924364 PMC: 3034841. DOI: 10.1038/mt.2010.211.


Local delivery of a collagen-binding FGF-1 chimera to smooth muscle cells in collagen scaffolds for vascular tissue engineering.

Pang Y, Wang X, Ucuzian A, Brey E, Burgess W, Jones K Biomaterials. 2009; 31(5):878-85.

PMID: 19853908 PMC: 2789982. DOI: 10.1016/j.biomaterials.2009.10.007.


Construction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogen.

Brewster L, Washington C, Brey E, Gassman A, Subramanian A, Calceterra J Biomaterials. 2007; 29(3):327-36.

PMID: 17950455 PMC: 2169381. DOI: 10.1016/j.biomaterials.2007.09.034.